Course Access
ACIPC is excited to announce that we are holding a Lunch and Learn webinar on Tuesday 19 May at 10:00 am AEST*
Join us for our May Lunch & Learn as we explore BEACON (Biothreats Emergence, Analysis and Communications Network) — an innovative open-access surveillance platform developed at the Boston University Center on Emerging Diseases.
In an era of increasing global health threats, early detection is everything. BEACON harnesses the power of a domain-adapted Large Language Model to support a worldwide network of disease experts in identifying and reporting outbreaks in real time. As an event-based informal surveillance system, it bridges the gap between emerging signals and coordinated public health responses.
This session will walk through how BEACON contributes to the rapid identification of novel disease threats, facilitates timely interventions, and strengthens global health security. Whether you work in public health, infectious disease, or emerging technology, this is an opportunity to see how AI is reshaping outbreak surveillance.
Don’t miss this engaging look at the future of biosurveillance.
Britta Lassmann, MD is an infectious diseases physician and health technology innovator with expertise in overseeing the development of applications at the intersection of clinical care, public health, analytics and technology. She is experienced in different disease tracking methodologies, tools and technologies with an appreciation of the cross-cutting scientific areas that support informal disease surveillance and risk predictions including epidemiology, clinical care, mathematical modeling, analytics, and technology. Dr. Lassmann is a graduate of the Medical University of Vienna, Austria. She completed her residency in Internal Medicine at the Mayo Clinic, Rochester and her fellowship in Infectious Diseases at Yale University. Subsequently, she served as a faculty member in the Division of Infectious Diseases at the University of California, Los Angeles and was the Program Director at the International Society for Infectious Diseases. She is also the co-founder of Global Second Opinion, focused on combining AI and medical expert opinions for rapid online medical specialty expertise. She is American Board-certified in Internal Medicine and Infectious Diseases.